Abstract
Apoptosis is often called programmed cell death and is defined as a self-directed cell destruction process. It is different from necrosis due to the activation of caspases during this process. Apoptosis is directly related to cancer progression and plays a vital role in carcinogenesis; all cytotoxic drugs and radiation therapy programs initiate apoptosis in tumor cells. Today, studies show that heterocyclic compounds that contain triazole functionality have anticancer activities; triazoles are 5- membered rings, which contain two carbon and three nitrogen atoms. Therefore, many researchers have synthesized these small active compounds as target structures and evaluated their apoptotic activities. The present review describes recent medicinal aspects of triazoles as anticancer agents that have been reported during the past few years. We hope that the bioactivity of triazole derivatives will be beneficial for the rational design of a new generation of small molecule drugs.
Keywords: Apoptosis, triazole, cancer, caspase-8, caspase-3, Bcl-2, cytochrome C.
Graphical Abstract
Current Drug Targets
Title:Recent Progress on Apoptotic Activity of Triazoles
Volume: 22 Issue: 16
Author(s): P. Çıkla-Süzgün and Ş.G. Küçükgüzel*
Affiliation:
- Vocational School of Health Services, Fenerbahçe University, Ataşehir, 34758, Istanbul,Turkey
Keywords: Apoptosis, triazole, cancer, caspase-8, caspase-3, Bcl-2, cytochrome C.
Abstract: Apoptosis is often called programmed cell death and is defined as a self-directed cell destruction process. It is different from necrosis due to the activation of caspases during this process. Apoptosis is directly related to cancer progression and plays a vital role in carcinogenesis; all cytotoxic drugs and radiation therapy programs initiate apoptosis in tumor cells. Today, studies show that heterocyclic compounds that contain triazole functionality have anticancer activities; triazoles are 5- membered rings, which contain two carbon and three nitrogen atoms. Therefore, many researchers have synthesized these small active compounds as target structures and evaluated their apoptotic activities. The present review describes recent medicinal aspects of triazoles as anticancer agents that have been reported during the past few years. We hope that the bioactivity of triazole derivatives will be beneficial for the rational design of a new generation of small molecule drugs.
Export Options
About this article
Cite this article as:
Çıkla-Süzgün P. and Küçükgüzel Ş.G.*, Recent Progress on Apoptotic Activity of Triazoles, Current Drug Targets 2021; 22 (16) . https://dx.doi.org/10.2174/1389450122666210208181128
DOI https://dx.doi.org/10.2174/1389450122666210208181128 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design, Synthesis and Biological Activity of New Hydroxamic Acids Containing 2-Imidazolylphenyl(oxy/thio)alkanoic Fragment
Current Bioactive Compounds Recombinant Human Semenogelin-1 (Sg1) and Sg1 (1-159) form Detergent Stable Amyloid like Aggregates in vitro
Protein & Peptide Letters Synthesis and Applications of Nanoflowers
Recent Patents on Nanotechnology A Glimpse of Matrix Metalloproteinases in Diabetic Nephropathy
Current Medicinal Chemistry Recent Advances on Liquid Chromatographic and Mass Spectrometric Analysis of Selective Estrogen Receptor Modulators (SERMs) in Biological Fluids
Current Chromatography NMR-based Metabolite Profiling of Pancreatic Cancer
Current Metabolomics Emerging Technologies, Recent Developments, and Novel Applications for Drug Metabolite Identification
Current Drug Metabolism Novel Anticancer Strategy Aimed at Targeting Shelterin Complexes by the Induction of Structural Changes in Telomeric DNA: Hitting two Birds with one Stone
Current Cancer Drug Targets Chitin Synthase As an Antifungal Target: Recent Advances
Current Medicinal Chemistry - Anti-Infective Agents Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery Redox Modification of Platelet Glycoproteins
Current Drug Targets Retrotransposon-Adenovirus Hybrid Vectors: Efficient Delivery and Stable Integration of Transgenes via a Two-Stage Mechanism
Current Gene Therapy Antibiotics as Inhibitor of Glutathione S-transferase: Biological Evaluation and Molecular Structure Studies
Current Drug Metabolism Phenolic Imidazole Derivatives with Dual Antioxidant/Antifungal Activity: Synthesis and Structure-Activity Relationship
Medicinal Chemistry Analysis of Glycosylation and Other Post-Translational Modifications by Mass Spectrometry
Current Analytical Chemistry Glutamate Dehydrogenase as a Promising Target for Hyperinsulinism Hyperammonemia Syndrome Therapy
Current Medicinal Chemistry Polydivinylbenzene Hollow Nanospheres as an Effective Fluorescent Sensing Platform for DNA Detection
Current Nanoscience Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders
Current Drug Metabolism Prevention of Renal Complications Induced by Non- Steroidal Anti-Inflammatory Drugs
Current Medicinal Chemistry A Divide-and-Conquer Strategy for the Prediction of Protein Contact Map
Letters in Drug Design & Discovery